AI Executive Investment Narrative:商业案例与董事会决策架构
重要说明: 本文是学习、作品集和内部架构训练材料, 不构成法律意见、监管解释、合规结论、审计意见、财务投资建议、会计确认、估值建议、董事会治理意见或生产上线批准。正式项目必须由机构授权角色结合司法辖区、牌照、客户群、产品、风险偏好、财务政策、模型风险、信息安全、隐私、供应商合同、内部审计和监管关系确认。访问日期按 2026-06-30 记录。
AI Executive Investment Narrative / Business Case / Board Decision Architecture 解读
面向对象: Senior AI PM / AI Product Architect / Enterprise Architect / CBAP-level BA / AI Value Office Lead / Portfolio Governance Lead / Financial Retail Transformation Owner。 核心问题: AI 产品和架构工作如何从 "promising use case" 转成 fundable executive decision: 有 outcome thesis、option architecture、causal value logic、risk appetite、architecture dependency、cost-to-learn、benefits realization、portfolio metrics 和 stop / scale / pivot gate。 学习目标: 建立 AI executive investment narrative 的高级心智模型, 能把 AI complaint intelligence、account opening modernization、AML triage、regulatory reporting automation、branch / contact-center copilots 等场景写成可被董事会、高管、CFO、COO、CIO/CTO、风险与审计共同挑战的决策包。
重要说明: 本文是学习、作品集和内部架构训练材料, 不构成法律意见、监管解释、合规结论、审计意见、财务投资建议、会计确认、估值建议、董事会治理意见或生产上线批准。正式项目必须由机构授权角色结合司法辖区、牌照、客户群、产品、风险偏好、财务政策、模型风险、信息安全、隐私、供应商合同、内部审计和监管关系确认。访问日期按 2026-06-30 记录。
Target Audience
| Role | 需要掌握的能力 |
|---|---|
| Senior AI PM | 把 use case 从功能叙事升级成 outcome thesis、option set、benefits realization 和 scale / stop decision。 |
| AI Architect / Enterprise Architect | 把目标架构、依赖、平台复用、技术债、控制能力和运行韧性翻译成投资选项和风险约束。 |
| CBAP-level BA | 把业务问题、流程证据、需求、验收标准、管理信息和证据包连接成可决策的 business case。 |
| AI Value Office / Portfolio Lead | 组合层管理资金、容量、风险、学习速度、平台能力和停止纪律。 |
| Risk / Compliance / Audit Partner | 用 risk appetite、control evidence、traceability 和 management action challenge 投资叙事。 |
| CFO / COO / CIO/CTO delegate | 分别挑战收益可兑现性、运营采用、平台经济性、成本、依赖和治理成本。 |
Learning Objectives
完成本文后, 应能独立完成七件事:
- 写出一个能被高管资助的 AI outcome thesis, 而不是功能愿望清单。
- 用 option architecture 展示 build / buy / partner / platform / process redesign / no-AI option 的取舍。
- 建立 business case model, 区分 baseline、causal value logic、leading indicator、lagging benefit、unit economics 和 finance recognition。
- 把 cost、value、risk、architecture dependency 和 confidence level 放在同一张 evidence table 中。
- 设计 board narrative: decision requested、options、tradeoffs、risk appetite、evidence、conditions、management action。
- 定义 discovery / pilot / release / scale / stop gates, 包含 cost-to-learn、kill criteria 和 benefits realization。
- 用 financial retail case 讲清 AI 投资如何在客户伤害、监管信任、运营效率和平台复用之间做取舍。
Executive Summary
AI 高管投资叙事不是把技术方案包装成 ROI。它是一套 decision architecture:
business problem and strategic context
-> outcome thesis
-> option architecture
-> causal value logic
-> evidence and confidence level
-> architecture dependency and control readiness
-> cost-to-learn and funding envelope
-> risk appetite and residual risk
-> benefits realization method
-> stop / scale / pivot gates
-> board decision and management action
低成熟度 AI business case 常见写法:
Use GenAI to automate customer service.
Expected benefit: reduce handle time by 30%.
Investment: model integration + RAG.
Risk: manageable with human review.
Decision: approve funding.
高级写法:
We propose a staged investment in regulated service intelligence for high-volume complaint and policy-answer workflows.
The first option funds an 8-week evidence stage, not enterprise scale.
The outcome thesis is that grounded AI assistance can reduce agent research load and improve policy citation quality without increasing complaint, reopen or customer harm rates.
The causal value logic depends on source freshness, workflow adoption, supervisor review, RAG citation quality and finance-recognized capacity release.
The board decision is to approve a capped discovery-to-pilot envelope, with explicit kill criteria, architecture conditions and risk appetite thresholds before scale funding.
核心观点:
Executives do not fund AI models. They fund managed options to improve business outcomes under uncertainty, with evidence that value can be realized and risk remains inside appetite.
Source Anchors
| Source | Official link | 本文使用方式 |
|---|---|---|
| NIST AI Risk Management Framework | https://www.nist.gov/itl/ai-risk-management-framework | 用 Govern / Map / Measure / Manage 组织 AI 投资中的风险识别、度量、管理、治理证据和持续改进。NIST 页面显示 AI RMF 1.0 正在修订, 且 2026 年发布 critical infrastructure profile concept note, 正式项目需按访问日期复核。 |
| ISO/IEC 42001:2023 AI management systems | https://www.iso.org/standard/81230.html | 用 AI management system、risk and opportunity、operation、performance evaluation、management review 和 continual improvement 组织 AI 投资治理。ISO 页面将该路径重定向到当前 ISO/IEC 42001 标准页, reference number 81230。 |
| FFIEC IT Examination Handbook InfoBase | https://ithandbook.ffiec.gov/ | 用 Management、Architecture Infrastructure and Operations、Development Acquisition and Maintenance 的 board oversight、IT investment planning、risk monitoring、project business case、architecture、asset、change 和 board reporting 语言校准金融机构场景。 |
| ISO/IEC/IEEE 42010:2022 Architecture Description | https://www.iso.org/standard/74393.html | 用 architecture description、stakeholder concerns、viewpoints、model kinds 和 architecture rationale 组织 board decision architecture 的视图和证据。 |
一句话:
AI investment narrative is the architecture description of an executive decision, not the storytelling layer after architecture is done.
1. Investment Thesis: 从 AI 项目请求到投资论点
AI investment thesis 不是 "我们应该采用 AI"。它要回答:
Which outcome do we want?
Why is AI a better option than process, rules, UX, staffing or vendor change?
What evidence would change our mind?
What architecture and control capabilities must exist before scale?
What risks are we willing or unwilling to take?
How cheaply can we learn before committing scale capital?
1.1 Weak vs Strong Thesis
| 维度 | 弱 thesis | 强 thesis |
|---|---|---|
| Outcome | "提升效率" | "把投诉 root-cause 分析周期从月度手工抽样改成每周 evidence-backed insight, 降低 repeat complaint 和 remediation delay。" |
| AI role | "使用 LLM 总结" | "AI 负责聚类、证据检索和 draft insight; regulatory interpretation、customer remediation 和 issue closure 由授权人负责。" |
| Causal logic | "AI 节省人工时间" | "如果 AI 提升 case classification 和 evidence retrieval, QA reviewer 可更快识别 systemic issue, 从而缩短 corrective action cycle。" |
| Evidence | "用户反馈很好" | "baseline、holdout、QA defect、complaint repeat rate、action closure time、finance-recognized capacity release。" |
| Risk | "human in the loop" | "高风险投诉结论必须引用 approved source, reviewer sign-off, customer harm threshold, stale source stop rule。" |
| Architecture | "接入企业模型" | "依赖 complaint taxonomy、case connector、RAG source authority、trace log、MI metric contract、human review queue。" |
| Funding ask | "批准项目预算" | "批准 8 周 cost-to-learn envelope, scale 资金另走 gate。" |
1.2 Thesis Template
We believe [AI capability] can improve [business outcome]
for [specific population / workflow]
because [causal value logic].
The investment is attractive if evidence shows:
- [value indicator] improves versus baseline,
- [quality / risk guardrail] remains inside appetite,
- [adoption indicator] proves workflow behavior change,
- [unit economics] remains viable,
- [architecture dependency] is reusable or controlled.
We will learn this through [evidence stage] at cost [cost-to-learn],
and we will stop, pivot or scale based on [decision criteria].
Financial retail example:
We believe AI-assisted AML triage can reduce low-risk alert investigation workload
for L1 analysts in two retail transaction-monitoring queues
because AI can retrieve case context, draft investigation summaries and highlight evidence gaps
while keeping final disposition with trained analysts.
The investment is attractive if shadow-mode evidence shows lower average handling time,
no decline in QA narrative quality, no unsupported escalation recommendation,
analyst adoption above threshold, and reusable case/RAG/evidence platform patterns.
We will learn this through a six-week shadow pilot with capped SME review cost.
We stop if critical evidence defects occur, pivot if analyst trust fails due to citation quality,
and scale only after release evidence proves controls, monitoring and review capacity.
2. Option Architecture: 投资不是 yes/no, 而是一组选项
董事会和高管不应只看到一个推荐方案。成熟 AI decision package 至少呈现三类选项:
No-action / baseline option
Process and control improvement option
AI-assisted workflow option
Platform / enterprise capability option
Vendor / partner option
Hybrid staged option
2.1 Option Architecture Table
| Option | 适合场景 | 好处 | 风险 / tradeoff | Evidence needed |
|---|---|---|---|---|
| Do nothing / monitor | 问题不严重或证据不足 | 不引入新风险和成本 | 机会成本、旧问题继续累积 | baseline trend、risk exposure、customer harm trend |
| Process redesign only | 痛点来自流程、权限、SOP、handoff | 成本低、风险低 | 不解决知识检索或复杂判断负担 | process mining、handoff defect、training impact |
| Rules / workflow automation | 规则明确、数据结构化 | 可解释、可控、低模型风险 | 覆盖不了非结构化证据和复杂文本 | rule coverage、exception rate、maintenance cost |
| AI assistant / copilot | 非结构化文本、摘要、检索、建议 | 快速增强员工能力 | adoption、hallucination、source freshness、review burden | eval、QA sample、workflow adoption、traceability |
| AI automation | 低风险高量、可逆、标准化 | 最大效率空间 | 客户伤害、自动化边界、incident velocity | risk appetite、control tests、rollback drill |
| Shared platform | 多 use case 重复能力明显 | 复用、成本、治理一致性 | 前期投入较高, 需产品化运营 | reuse count、platform economics、service catalog |
| Vendor product | 能快速获得成熟能力 | time-to-market 快 | vendor lock-in、data boundary、evidence export | third-party risk, exit plan, evidence completeness |
2.2 Real Options Thinking
AI 投资的不确定性很高, 所以早期 funding 应买 "学习权", 而不是直接买规模化承诺。
| Option concept | AI investment translation |
|---|---|
| Option premium | discovery / pilot 的小额资金和稀缺 SME capacity。 |
| Exercise condition | 当 value、risk、adoption、architecture readiness 达到阈值时, 才进入 release / scale。 |
| Expiry | 学习窗口结束日期, 防止 pilot 无期限延长。 |
| Abandonment value | 早停释放 capacity, 同时留下 reusable eval set、failure taxonomy、data quality insight。 |
| Compound option | 一个 use case 可以验证 RAG、eval、gateway、human review 等平台能力, 为后续组合创造选择权。 |
成熟表达:
The first funding decision is not "approve AI at scale"; it is "buy enough learning to decide whether scale is justified."
3. Business Case Model: 从 ROI 表格到因果价值模型
AI business case 必须避免把 "AI 输出质量" 直接等同于财务收益。中间需要完整 causal chain:
AI capability
-> behavior quality
-> workflow adoption
-> process performance
-> business outcome
-> financial / risk benefit
-> recognized benefit
3.1 Business Case Layers
| Layer | 问题 | Evidence |
|---|---|---|
| Baseline | 当前业务量、成本、质量、风险、等待时间、客户影响是什么 | workflow data、finance cost model、QA、complaints、incidents |
| Intervention | AI 改变哪个步骤、谁使用、AI 权限到哪一级 | target process、AI role、RACI、architecture boundary |
| Leading indicators | scale 前能快速看见什么信号 | eval score、citation correctness、acceptance rate、review time |
| Lagging benefits | 业务结果是否变好 | AHT、backlog、STP、loss avoided、complaint repeat、regulatory cycle time |
| Guardrails | 不允许用什么代价换收益 | harm, policy breach, fairness, privacy, AML quality, source freshness |
| Unit economics | 每个合格价值事件的全成本是多少 | model cost、platform allocation、review、QA、support、training |
| Attribution | 怎么知道改善来自 AI 与流程改变 | holdout、before-after with control、cohort comparison、process mining |
| Recognition | 谁能确认收益进入管理账 | business owner、finance reviewer、risk owner、operations owner |
3.2 Benefit Types
| Benefit type | 金融零售例子 | 需要防止的误报 |
|---|---|---|
| Productivity capacity | Contact-center agent assist 缩短政策查询时间 | 把理论节省分钟数直接当现金节省, 忽略返工和审核成本。 |
| Cost avoidance | Regulatory reporting automation 减少临时外包和 close-cycle surge | 把一次性峰值避免当长期 run-rate saving。 |
| Risk reduction | AML triage 提升 evidence completeness, 降低 QA finding | 用 "更多 alerts reviewed" 代替风险降低证据。 |
| Revenue enablement | Account opening modernization 降低 abandonment, 提升合格开户 | 忽略 fraud / KYC review 增量成本和不合格申请过滤。 |
| Customer experience | Complaint intelligence 缩短 root-cause corrective action | 只看 sentiment, 不看 repeat complaint 和 remediation timeliness。 |
| Platform leverage | Shared RAG / eval / gateway 降低后续用例接入成本 | 把平台 sunk cost 平摊后仍没有 reuse evidence。 |
3.3 Confidence Level
商业案例中的每个数字都应标注 confidence:
| Confidence | 证据标准 | 决策含义 |
|---|---|---|
| Low | SME estimate、vendor benchmark、small interview signal | 只能支持 discovery, 不能支持 scale commitment。 |
| Medium | baseline 数据可用, pilot 或 offline eval 有方向性结果 | 可支持 pilot 或 limited release, 需要 stronger gate。 |
| High | 生产 cohort、holdout、QA、finance recognition 和 risk trend 支撑 | 可支持 scale decision, 仍需 monitor。 |
| Declining | 生产分布、成本、adoption 或风险趋势恶化 | hold、pivot 或 stop。 |
3.4 Cost-to-Learn
高管投资包要明确:
What do we need to learn?
What is the cheapest credible way to learn it?
Which scarce capacities are consumed?
What evidence will we have by what date?
Which decision will that evidence enable?
| Learning question | Cheap credible test | 不成熟做法 |
|---|---|---|
| AI 能否理解投诉原因 | 历史投诉样本 offline eval + QA reviewer rubric | 直接接入生产投诉系统做 live pilot |
| 员工会不会采用 copilot | concierge pilot 或 limited workflow trial | 只做 demo 后问满意度 |
| RAG 引用是否可靠 | controlled knowledge set + source freshness tests | 用全量知识库, 后期再补治理 |
| 收益是否可兑现 | 4 周 cohort + finance baseline review | 用 vendor ROI calculator |
| 风险能否受控 | shadow mode + red-team + stop-rule drill | 写 "human review" 作为单一控制 |
4. Cost / Value / Risk Evidence
AI board case 的证据必须三账合一: value account、risk account、capacity / cost account。
4.1 Evidence Table
| Evidence object | Minimum content | Decision use |
|---|---|---|
| Baseline fact sheet | volume、cycle time、cost、quality、risk、complaint、manual effort | 判断问题是否值得投资 |
| Outcome thesis | target outcome、population、AI role、causal path | 判断叙事是否具体 |
| Option comparison | no-AI、process、rules、AI、vendor、platform options | 判断是否过早锁定方案 |
| Architecture dependency map | systems、data、RAG、model、tools、workflow、controls、vendors | 判断 scale 条件和 hidden cost |
| Risk appetite mapping | unacceptable outcomes、thresholds、review forum、stop rule | 判断风险是否可接受 |
| Eval and QA pack | test set、rubric、failure taxonomy、reviewer evidence | 判断 AI 行为质量 |
| Adoption evidence | eligible users、repeat use、acceptance、override reason、manager cadence | 判断价值能否进入流程 |
| Unit economics | cost per qualified value event, review cost, support cost | 判断 scale 后是否成立 |
| Benefits register | baseline、target、owner、recognition method、confidence | 判断收益兑现纪律 |
| Management action log | amber/red issue、owner、due date、closure evidence | 判断治理是否真实运行 |
4.2 Risk Appetite Translation
| Risk appetite statement | Investment implication |
|---|---|
| No appetite for AI making final adverse customer decisions without authorized human decision | Credit, complaint denial, account closure and AML conclusions remain human-owned unless explicitly approved. |
| Low appetite for unsupported regulated customer communication | Customer-facing GenAI requires source citation, approved language, QA sampling and stop thresholds. |
| Limited appetite for vendor concentration in material AI systems | Board case must show model / vendor exposure, fallback plan and exit rights. |
| Low appetite for untraceable AI-assisted records | Investment must fund trace logging, evidence retention and reconstructability. |
| Appetite for controlled experimentation in internal productivity workflows | Discovery and pilot funding can move faster if data, scope and customer impact are constrained. |
4.3 Architecture Dependency as Investment Evidence
Architecture is not technical appendix. It changes the funding decision.
| Dependency | Board-relevant question |
|---|---|
| Model gateway | Can management control model routes, costs, versions, logs and fallbacks? |
| RAG / knowledge service | Are sources approved, fresh, permission-filtered and citable? |
| Workflow integration | Does AI output actually enter the work system, or remain side-channel advice? |
| Human review queue | Is there enough SME and supervisor capacity to keep risk controls credible? |
| Eval platform | Can releases and prompt / model changes be regression-tested? |
| Observability | Can value, harm, cost, adoption, latency and incidents be monitored? |
| Evidence binder | Can audit reconstruct claims, approvals, outputs and management actions? |
| Vendor contract | Are evidence export, data boundaries, exit and resilience terms sufficient? |
高级表达:
A business case that excludes architecture dependency is an unfunded risk transfer from product to operations, risk and technology.
5. Board Narrative Structure
董事会材料不应是项目状态汇报。它应围绕 decision requested 构造。
5.1 Recommended Board Storyline
1. Decision requested
2. Strategic context and risk appetite fit
3. Business problem and baseline evidence
4. Outcome thesis and causal value logic
5. Options considered and recommended option
6. Architecture and operating model dependencies
7. Business case model and confidence level
8. Cost, value and risk evidence
9. Governance gates and management information
10. Stop / scale / pivot criteria
11. Conditions, residual risk and management actions
5.2 Board Packet Sections
| Section | Good content | Weak content |
|---|---|---|
| Decision requested | "Approve USD X discovery envelope and conditional pilot gate; no scale funding requested." | "Approve AI transformation program." |
| Executive conclusion | one-page recommendation with conditions and stop rules | long technical summary |
| Baseline | quantified current state with source owners | anecdotal pain |
| Option architecture | 3-5 options with value/risk/cost/tradeoffs | only preferred solution |
| Business case | causal chain, confidence, unit economics, benefit owner | single ROI percentage |
| Architecture | dependency map and platform leverage | model diagram only |
| Risk appetite | thresholds, unacceptable outcomes, residual risk owner | generic "risk is manageable" |
| MI and gates | metrics, cadence, action path | "we will monitor" |
| Evidence pack | references to artifacts and owners | screenshots and slide notes |
5.3 Executive Memo Example: Account Opening Modernization
Decision requested:
Approve a staged investment to modernize AI-assisted account opening evidence review for mobile retail deposit applications.
Stage 1 funds discovery and shadow-mode pilot; scale funding is not requested.
Outcome thesis:
AI-assisted document extraction and checklist generation can reduce manual review cycle time and application abandonment
while preserving KYC controls, human final decision, audit evidence and recourse.
Why now:
Application abandonment is high in missing-document journeys.
Operations review queues are creating SLA pressure.
Current OCR and manual checklist processes are inconsistent across channels.
Recommended option:
Hybrid staged option: shared onboarding AI capability service with product-specific policy profiles,
model gateway, OCR abstraction, RAG policy sources, workflow connector and evidence capture.
Conditions:
No automated final rejection.
High-risk identity, sanctions, fraud and vulnerable-customer scenarios route to human review.
Scale requires QA evidence, source freshness, trace completeness, adoption and finance-recognized benefit.
6. Governance Gates
Investment governance should be staged by evidence, not by calendar milestone.
6.1 Gate Stack
| Gate | Decision | Required evidence |
|---|---|---|
| Intake gate | enter discovery / park / reject | owner, problem, baseline signal, AI fit hypothesis, initial risk tier |
| Discovery gate | fund pilot / pivot / stop | workflow map, no-AI option, data readiness, architecture sketch, risk appetite fit |
| Pilot gate | limited release candidate / continue / stop | eval, QA, SME review, cost, adoption signal, control design, failure taxonomy |
| Release gate | production limited release / no-go | runbook, monitoring, rollback, risk sign-off, model/prompt/RAG/tool versioning |
| Scale gate | expand / hold / restrict / stop | realized benefits, unit economics, incident trend, adoption, platform capacity |
| Portfolio rebalance | fund / merge / retire / platformize | portfolio metrics, capacity, risk concentration, opportunity cost |
6.2 Gate Decision Record
| Field | 内容 |
|---|---|
| Gate ID | stable decision id |
| Use case / portfolio theme | complaint intelligence, account opening, AML, reporting, copilot |
| Decision | fund, hold, stop, pivot, scale, restrict, platformize |
| Evidence reviewed | baseline, eval, QA, risk, architecture, finance, operations |
| Confidence level | Low / Medium / High / Declining |
| Conditions | scope, control, monitoring, review, funding conditions |
| Kill criteria | specific thresholds that stop funding or expansion |
| Residual risk | accepted risk, owner, expiry and review cadence |
| Management action | owner, due date, closure evidence |
6.3 Kill Criteria
Kill criteria must be written before pilot starts:
| Scenario | Kill / pivot criteria |
|---|---|
| AI complaint intelligence | Stop if systemic issue clustering cannot reach agreed QA precision or if sensitive complaint categories are misclassified beyond appetite. |
| Account opening modernization | Stop automation expansion if false missing-document recommendations or unsupported rejection recommendations exceed threshold. |
| AML triage | Stop if AI summaries omit critical evidence or produce unsupported escalation / closure recommendations. |
| Regulatory reporting automation | Stop if lineage, calculation reproducibility or maker-checker evidence cannot be reconstructed. |
| Branch / contact-center copilot | Stop customer-facing expansion if unsupported policy claim, stale source citation or high-risk topic bypass exceeds appetite. |
7. Portfolio Metrics and Management Information
Executive investment decisions need portfolio metrics, not only use case metrics.
7.1 Portfolio Metric Taxonomy
| Category | Board / executive question | Metric examples |
|---|---|---|
| Flow | Is the AI investment funnel healthy? | ideas by stage, WIP, cycle time to evidence, stage aging |
| Value | Is value proven or estimated? | qualified value events, finance-recognized benefits, forecast vs recognized |
| Risk | Is residual risk inside appetite? | red/amber appetite breaches, customer harm, incident severity |
| Evidence | Are decisions evidence-backed? | gates with complete evidence, trace reconstructability, eval coverage |
| Cost | Are unit economics and platform costs controlled? | cost per value event, review cost, model spend, platform allocation |
| Adoption | Do users change workflow behavior? | eligible repeat adoption, accepted output, override reason, manager cadence |
| Architecture | Are investments building reusable capabilities? | platform reuse, duplicate capability count, integration debt, vendor concentration |
| Benefits | Are benefits realized after release? | benefit confidence, finance sign-off, capacity redeployment, risk reduction |
| Decision discipline | Are we willing to stop? | stop decisions, pivot decisions, scale decisions with gate evidence |
7.2 Management Information Path
AI system events
-> value / risk / adoption / cost metrics
-> metric contracts and lineage
-> portfolio dashboard
-> executive decision pack
-> action log
-> benefits realization and risk review
MI quality standard:
| Rule | 意义 |
|---|---|
| Every board number has a metric contract | 避免 slide-local calculation。 |
| Every metric maps to a decision | 没有决策用途的指标不进入 board pack。 |
| Every amber/red has owner and action | 风险信号不能只被展示。 |
| Every benefit has recognition method | 不把估算收益当兑现收益。 |
| Every scale decision has stop criteria | scale 后仍可回退或限制。 |
8. Scenario Planning
AI investment narrative 要能回答 "如果假设不成立怎么办"。
8.1 Scenario Set
| Scenario | Signal | Management response |
|---|---|---|
| Base case | value improves, risk inside appetite, adoption stable, cost controlled | continue gate path, prepare scale evidence |
| Upside | value and adoption strong, platform reuse high | accelerate platform runway, expand controlled cohorts |
| Value miss | model works but workflow outcome does not improve | pivot to process redesign, revise AI role, stop scale |
| Adoption miss | AI quality acceptable but employees bypass it | redesign workflow, manager cadence, incentives, UX; hold funding |
| Risk breach | customer harm, policy error, privacy or evidence failure | contain, stop expansion, remediate, risk review |
| Cost drift | token, review, support or vendor cost exceeds unit economics | route optimization, scope restriction, vendor renegotiation, stop |
| Architecture blocker | data source, workflow connector or evidence path not ready | convert to platform / data investment or stop use case |
| Regulatory / policy change | appetite or requirement changes | re-tier use case, freeze high-risk path, update evidence pack |
8.2 Assumption Register
| Assumption | Evidence needed | Trigger if false |
|---|---|---|
| Employees will adopt AI inside target workflow | repeat adoption and accepted output | workflow redesign or stop |
| RAG sources are authoritative and fresh | source freshness metrics and citation QA | pause regulated answers |
| Human review capacity is sufficient | queue age, review time, reviewer coverage | restrict scope or fund ops capacity |
| Benefits can be recognized by finance | baseline and redeployment evidence | reclassify as quality / risk benefit |
| Architecture pattern is reusable | second use case reuse and lower integration time | keep as local capability, do not platformize |
9. Stop / Scale / Pivot Decision
Scale is a new investment decision, not a reward for a successful demo.
9.1 Decision Matrix
| Evidence pattern | Decision | Rationale |
|---|---|---|
| Value green, risk green, adoption green, unit economics green, architecture reusable | Scale | Evidence supports broader deployment with monitoring. |
| Value green, risk amber, controls improving | Limited scale / hold | Value exists, but expansion must wait for control maturity. |
| Value amber, risk green, adoption high | Pivot | Users want help, but value logic or workflow target needs adjustment. |
| Value green, adoption low | Redesign workflow | AI capability may work, but change management or UX is blocking benefit. |
| Risk red | Stop / restrict | Customer harm, regulatory, privacy or control failure overrides value case. |
| Cost red | Optimize / restrict / stop | Unit economics not viable at scale. |
| Architecture dependency red | Convert to platform or data investment | Use case cannot scale until shared capability is funded. |
| Confidence declining after release | Hold / roll back | Production evidence invalidates earlier assumptions. |
9.2 Stop Decision Is a Governance Win
Stopping a weak AI investment creates value:
- Releases scarce product, engineering, data, risk and SME capacity.
- Preserves evidence and failure taxonomy for future use.
- Avoids operational drag from low-adoption tools.
- Protects risk appetite and management credibility.
- Redirects funding to platform runway or higher-confidence outcomes.
Mature interview statement:
I treat stop decisions as portfolio health signals. If no AI pilots are stopped, the organization is probably funding optimism instead of learning.
10. Evidence Pack
10.1 Evidence Binder Structure
| Folder | Contents |
|---|---|
| 01-decision-request | executive memo, decision owner, decision date, requested funding |
| 02-business-problem | baseline fact sheet, process map, customer / employee evidence |
| 03-option-architecture | options, tradeoff analysis, no-AI alternative, recommendation |
| 04-business-case | causal value logic, benefit register, unit economics, confidence |
| 05-architecture | system context, data flow, AI role, dependency map, platform reuse |
| 06-risk-appetite | risk tier, controls, residual risk, stop rules, exceptions |
| 07-eval-and-quality | eval set, rubric, QA result, failure taxonomy, regression evidence |
| 08-adoption-and-ops | adoption metrics, training, manager cadence, support model, runbook |
| 09-management-info | metric contracts, dashboard, thresholds, action log |
| 10-benefits-realization | baseline, target, finance review, realized benefits, post-review |
10.2 Narrative-to-Evidence Traceability
| Board claim | Required evidence |
|---|---|
| "The use case targets a material problem." | baseline volume, cost, risk and customer impact |
| "AI is the right intervention." | option comparison and no-AI alternative |
| "Value can be realized." | causal logic, adoption, workflow outcome and finance method |
| "Risk is within appetite." | risk tier, controls, eval, incidents, residual risk owner |
| "Architecture can scale." | dependency map, platform capacity, observability, support |
| "Management can stop if needed." | kill criteria, feature flags, rollback, action path |
11. Anti-Patterns
| Anti-pattern | Why it fails | Better practice |
|---|---|---|
| Technology-first pitch | Executives fund outcomes, not model enthusiasm | Start with business problem and decision requested |
| Single-option recommendation | Prevents real tradeoff discussion | Show no-AI, process, rules, AI, vendor and platform options |
| ROI without causal chain | Savings cannot be trusted | Link AI behavior to workflow, outcome and recognition |
| Human review as magic control | Review capacity, quality and evidence may fail | Define reviewer coverage, queue, override reason and QA |
| Pilot success equals scale approval | Pilot scope may not represent production | Separate release and scale gates |
| Benefits without owner | Value becomes slideware | Assign business and finance recognition owner |
| Architecture hidden in appendix | Dependencies determine feasibility and cost | Put dependency map in executive narrative |
| No kill criteria | Pilot becomes sunk-cost project | Write stop / pivot / scale rules before funding |
| Average metrics only | High-risk segments can be harmed | Segment by product, channel, customer, risk tier and language |
| Board pack as status report | No decision, no governance | Lead with fund, scale, hold, stop, remediate or accept risk |
12. Financial Retail Examples
12.1 AI Complaint Intelligence
| Decision element | Example |
|---|---|
| Outcome thesis | Reduce systemic complaint detection time and improve corrective action prioritization. |
| AI role | Cluster complaints, retrieve evidence, draft root-cause hypotheses, flag repeat themes. |
| Human boundary | Regulatory interpretation, remediation decision and customer communication remain authorized human decisions. |
| Value evidence | repeat complaint rate, action closure time, issue detection lag, QA review quality. |
| Risk appetite | Low appetite for unsupported regulatory conclusion or sensitive complaint misclassification. |
| Architecture dependency | complaint taxonomy, case connector, source authority, evidence trace, MI dashboard. |
| Stop rule | stop expansion if high-severity complaint categories are misclassified beyond threshold. |
12.2 Account Opening Modernization
| Decision element | Example |
|---|---|
| Outcome thesis | Improve onboarding completion and reduce manual review cycle time without weakening KYC controls. |
| AI role | document extraction, missing-document checklist, application summary, policy retrieval. |
| Human boundary | final approve / decline, sanctions/fraud escalation and adverse action explanation remain controlled. |
| Value evidence | abandonment, time-to-open, rework, manual review rate, qualified approval cycle time. |
| Risk appetite | no unsupported final rejection, strong recourse and evidence retention. |
| Architecture dependency | OCR abstraction, model gateway, product policy profile, workflow connector, audit record. |
| Stop rule | stop if false missing-document or unsupported rejection recommendation exceeds appetite. |
12.3 AML Triage
| Decision element | Example |
|---|---|
| Outcome thesis | Reduce low-risk alert handling time and improve narrative completeness. |
| AI role | retrieve context, summarize case, propose checklist, identify evidence gaps. |
| Human boundary | final closure, escalation and suspicious activity conclusion remain analyst-owned. |
| Value evidence | AHT, backlog age, QA narrative defect, escalation quality, review capacity. |
| Risk appetite | no appetite for unsupported closure or missed critical evidence. |
| Architecture dependency | case system connector, transaction data entitlement, policy RAG, reviewer workflow. |
| Stop rule | stop if AI omits critical evidence in material samples or causes QA regression. |
12.4 Regulatory Reporting Automation
| Decision element | Example |
|---|---|
| Outcome thesis | Shorten report production cycle and improve lineage reconstructability. |
| AI role | draft variance explanations, map source changes, generate evidence checklist. |
| Human boundary | attestation, interpretation, filing and material judgment remain authorized roles. |
| Value evidence | close-cycle time, rework, evidence completeness, issue aging, audit sample pass. |
| Risk appetite | low appetite for untraceable numbers or unsupported explanations. |
| Architecture dependency | data lineage, metric contracts, source-of-record, maker-checker workflow, evidence binder. |
| Stop rule | stop automation if calculation lineage or reviewer evidence cannot be reconstructed. |
12.5 Branch / Contact-Center Copilots
| Decision element | Example |
|---|---|
| Outcome thesis | Improve policy-answer quality and reduce agent research time in bounded service journeys. |
| AI role | retrieve policy, draft response, suggest next-best operational step. |
| Human boundary | customer-visible communication, fee commitments, complaint handling and advice boundaries remain controlled. |
| Value evidence | first-contact resolution, AHT, QA fail, reopen, accepted output, override reason. |
| Risk appetite | low appetite for stale policy citation, unauthorized advice or customer harm. |
| Architecture dependency | source freshness, RAG ACL, model gateway, CRM integration, QA sampling. |
| Stop rule | pause expansion if unsupported claim rate, stale source hit or high-risk bypass breaches threshold. |
13. Interview Answers
Q1: How do you turn an AI architecture proposal into a fundable executive decision?
30 秒版本:
I start with the decision, not the technology. I define the outcome thesis, compare options including no-AI and process redesign, show causal value logic, map architecture dependencies, quantify cost-to-learn, and attach risk appetite thresholds. Then I ask for staged funding with stop, pivot and scale criteria instead of asking for full-scale approval.
2 分钟版本:
I would convert the architecture proposal into an investment decision package. First, I state the business problem and baseline: volume, cost, cycle time, quality and risk. Second, I define the AI role and the human accountability boundary. Third, I present option architecture: no action, process redesign, rules automation, AI-assisted workflow, vendor option and platform option. Fourth, I build a causal value model from AI behavior to workflow adoption to business outcome to finance-recognized benefit. Fifth, I show architecture dependencies such as model gateway, RAG source authority, workflow connector, evaluation, observability and evidence binder. Finally, I define gates: discovery, pilot, release, scale and stop. The funding request buys the next evidence stage, not blind scale.
Q2: What makes an AI business case credible to a CFO?
30 秒版本:
It separates estimated benefit from recognized benefit. A credible case has baseline, unit economics, adoption proof, quality proof, risk guardrails, cost-to-serve, attribution method and finance owner. It does not multiply theoretical time saved by salary and call it ROI.
Q3: How would you handle a high-value but high-risk AI use case?
30 秒版本:
I would not reject it automatically, but I would buy learning in smaller stages. Use shadow mode, limited cohorts, human accountability, stricter eval, stronger monitoring and explicit kill criteria. Scale requires separate approval after evidence proves value and risk controls.
Q4: What is the role of architecture in board-level AI investment?
30 秒版本:
Architecture shows whether the business case can actually scale. Without source authority, model gateway, workflow integration, review capacity, observability, evidence retention and fallback, the ROI is an assumption and the risk is being transferred to operations.
Q5: How do you explain stop rules without making the project look weak?
30 秒版本:
Stop rules make the investment stronger because they show management knows what evidence would change the decision. In AI, uncertainty is normal. The mature move is to define cost-to-learn, kill criteria and pivot options before spending scale money.
14. Portfolio Exercise
Build a board decision packet for one financial retail AI investment.
Exercise Setup
Choose one:
| Case | Suggested scope |
|---|---|
| AI complaint intelligence | Detect systemic complaint themes and accelerate corrective action. |
| Account opening modernization | Assist document review and missing-document checklist for mobile onboarding. |
| AML triage | Assist low-risk alert review with summary and evidence checklist. |
| Regulatory reporting automation | Assist variance explanation and evidence binder creation. |
| Branch / contact-center copilot | Assist staff with grounded policy answers and workflow guidance. |
Required Artifacts
| Artifact | Completion standard |
|---|---|
| Outcome thesis | One paragraph with population, AI role, causal logic and boundary. |
| Option architecture | At least four options, including no-AI or process-only option. |
| Business case model | Baseline, leading indicators, lagging benefits, unit economics and recognition owner. |
| Cost / value / risk table | Evidence, confidence level, source owner and decision use. |
| Architecture dependency map | Model, data, workflow, human review, controls, observability, vendor. |
| Board narrative | Decision requested, recommendation, tradeoffs, conditions, residual risk. |
| Gate plan | Discovery, pilot, release, scale and stop criteria. |
| Evidence pack index | Trace every claim to evidence object and owner. |
Scoring Rubric
| Dimension | Strong answer |
|---|---|
| Executive clarity | The first page states the exact decision requested. |
| Investment logic | Funding request buys evidence and options, not optimism. |
| Architecture rigor | Dependencies and control readiness are visible in the decision. |
| Benefits discipline | Value is tied to baseline, adoption, quality, unit economics and finance recognition. |
| Risk appetite | Thresholds and unacceptable outcomes are explicit. |
| Stop / scale discipline | Scale is conditional; stop rules are written before funding. |
| Traceability | Narrative claims link to evidence artifacts. |
Final memory card:
Outcome thesis = why invest.
Option architecture = what choices exist.
Causal value logic = how value happens.
Cost-to-learn = what evidence costs.
Risk appetite = what cannot be traded away.
Architecture dependency = what must be true to scale.
Benefits realization = how value is recognized.
Stop / scale / pivot gates = how management stays in control.
Evidence traceability = why the board can trust the narrative.